{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:09:34Z","timestamp":1785758974539,"version":"3.56.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T00:00:00Z","timestamp":1527206400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.drudis.2018.05.020","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T21:55:41Z","timestamp":1526594141000},"page":"1426-1435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Structural basis for selective inhibition of antibacterial target MraY, a membrane-bound enzyme involved in peptidoglycan synthesis"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3477-4795","authenticated-orcid":false,"given":"Jenny","family":"Hering","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin","family":"Dunevall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareta","family":"Ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Br\u00e4nd\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2018.05.020_bib0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ja.2013.49","article-title":"Prospects for new antibiotics: a molecule-centered perspective","volume":"67","author":"Walsh","year":"2014","journal-title":"J. Antibiot."},{"key":"10.1016\/j.drudis.2018.05.020_bib0010","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1128\/JB.186.6.1747-1757.2004","article-title":"Phospho-N-acetyl-muramyl-pentapeptide translocase from Escherichia coli: catalytic role of conserved aspartic acid residues","volume":"186","author":"Lloyd","year":"2004","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.drudis.2018.05.020_bib0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1021\/cb100269f","article-title":"Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylococcus aureus","volume":"6","author":"Campbell","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.drudis.2018.05.020_bib0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tibtech.2012.12.006","article-title":"Combination approaches to combat multidrug-resistant bacteria","volume":"31","author":"Worthington","year":"2013","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.drudis.2018.05.020_bib0025","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad7364","article-title":"TarO-specific inhibitors of wall teichoic acid biosynthesis restore beta-lactam efficacy against methicillin-resistant staphylococci","volume":"8","author":"Lee","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.drudis.2018.05.020_bib0030","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1093\/nar\/gkf418","article-title":"Identification of 113 conserved essential genes using a high-throughput gene disruption system in Streptococcus pneumoniae","volume":"30","author":"Thanassi","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.drudis.2018.05.020_bib0035","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1126\/science.1236501","article-title":"Crystal structure of MraY, an essential membrane enzyme for bacterial cell wall synthesis","volume":"341","author":"Chung","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.drudis.2018.05.020_bib0040","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature17636","article-title":"Structural insights into inhibition of lipid I production in bacterial cell wall synthesis","volume":"533","author":"Chung","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2018.05.020_bib0045","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nchembio.2270","article-title":"MraY-antibiotic complex reveals details of tunicamycin mode of action","volume":"13","author":"Hakulinen","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.drudis.2018.05.020_bib0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41594-018-0031-y","article-title":"GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation","volume":"25","author":"Yoo","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.drudis.2018.05.020_bib0055","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/glycob\/4.6.768","article-title":"A family of UDP-GlcNAc\/MurNAc: polyisoprenol-P GlcNAc\/MurNAc-1-P transferases","volume":"4","author":"Lehrman","year":"1994","journal-title":"Glycobiology"},{"key":"10.1016\/j.drudis.2018.05.020_bib0060","doi-asserted-by":"crossref","first-page":"29R","DOI":"10.1093\/glycob\/cwi065","article-title":"Modeling bacterial UDP-HexNAc: polyprenol-P HexNAc-1-P transferases","volume":"15","author":"Price","year":"2005","journal-title":"Glycobiology"},{"key":"10.1016\/j.drudis.2018.05.020_bib0065","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1574-6968.2000.tb09335.x","article-title":"Conserved cytoplasmic motifs that distinguish sub-groups of the polyprenol phosphate: N-acetylhexosamine-1-phosphate transferase family","volume":"191","author":"Anderson","year":"2000","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.drudis.2018.05.020_bib0070","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1021\/bi00578a008","article-title":"Mechanism of action of tunicamycin on the UDP-GlcNAc:dolichyl-phosphate Glc-NAc-1-phosphate transferase","volume":"18","author":"Heifetz","year":"1979","journal-title":"Biochemistry"},{"key":"10.1016\/j.drudis.2018.05.020_bib0075","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2174\/138945009788488369","article-title":"Structure, expression, and regulation of UDP-GlcNAc: dolichol phosphate GlcNAc-1-phosphate transferase (DPAGT1)","volume":"10","author":"Bretthauer","year":"2009","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.drudis.2018.05.020_bib0080","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1073\/pnas.53.4.881","article-title":"Lipid-phosphoacetylmuramyl-pentapeptide and lipid-phosphodisaccharide-pentapeptide: presumed membrane transport intermediates in cell wall synthesis","volume":"53","author":"Anderson","year":"1965","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2018.05.020_bib0085","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0006-291X(65)90873-9","article-title":"Evidence for an initial acceptor of UDP-NAc-muramyl-pentapeptide in the synthesis of bacterial mucopeptide","volume":"18","author":"Struve","year":"1965","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drudis.2018.05.020_bib0090","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1128\/jb.173.3.1021-1026.1991","article-title":"The Escherichia coli mraY gene encoding UDP-N-acetylmuramoyl-pentapeptide: undecaprenyl-phosphate phospho-N-acetylmuramoyl-pentapeptide transferase","volume":"173","author":"Ikeda","year":"1991","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.drudis.2018.05.020_bib0095","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1365-2958.1999.01623.x","article-title":"Topological analysis of the MraY protein catalysing the first membrane step of peptidoglycan synthesis","volume":"34","author":"Bouhss","year":"1999","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.drudis.2018.05.020_bib0100","doi-asserted-by":"crossref","first-page":"29974","DOI":"10.1074\/jbc.M314165200","article-title":"Purification and characterization of the bacterial MraY translocase catalyzing the first membrane step of peptidoglycan biosynthesis","volume":"279","author":"Bouhss","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2018.05.020_bib0105","doi-asserted-by":"crossref","first-page":"38844","DOI":"10.1074\/jbc.M111.301085","article-title":"Preparative scale cell-free production and quality optimization of MraY homologues in different expression modes","volume":"286","author":"Ma","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2018.05.020_bib0110","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/pro.2297","article-title":"Fluorescent probe for high-throughput screening of membrane protein expression","volume":"22","author":"Backmark","year":"2013","journal-title":"Protein Sci."},{"key":"10.1016\/j.drudis.2018.05.020_bib0115","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1128\/AAC.40.7.1640","article-title":"Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli","volume":"40","author":"Brandish","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2018.05.020_bib0120","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1128\/AAC.48.3.897-902.2004","article-title":"Fluorescence detection-based functional assay for high-throughput screening for MraY","volume":"48","author":"Stachyra","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2018.05.020_bib0125","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1177\/1087057112436885","article-title":"A high-throughput, homogeneous, fluorescence resonance energy transfer-based assay for phospho-N-acetylmuramoyl-pentapeptide translocase (MraY)","volume":"17","author":"Shapiro","year":"2012","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.drudis.2018.05.020_bib0130","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1074\/jbc.M115.664292","article-title":"Lipid requirements for the enzymatic activity of MraY translocases and in vitro reconstitution of the lipid II synthesis pathway","volume":"291","author":"Henrich","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2018.05.020_bib0135","doi-asserted-by":"crossref","first-page":"8919","DOI":"10.1021\/bi8006274","article-title":"Active site mapping of MraY, a member of the polyprenyl-phosphate N-acetylhexosamine 1-phosphate transferase superfamily, catalyzing the first membrane step of peptidoglycan biosynthesis","volume":"47","author":"Al-Dabbagh","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.drudis.2018.05.020_bib0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2174\/187152606784112128","article-title":"Phospho-MurNAc-pentapeptide translocase (MraY) as a target for antibacterial agents and antibacterial proteins","volume":"6","author":"Bugg","year":"2006","journal-title":"Infect. Disord. Drug Targets"},{"key":"10.1016\/j.drudis.2018.05.020_bib0145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.biochi.2016.06.005","article-title":"Catalytic mechanism of MraY and WecA, two paralogues of the polyprenyl-phosphate N-acetylhexosamine 1-phosphate transferase superfamily","volume":"127","author":"Al-Dabbagh","year":"2016","journal-title":"Biochimie"},{"key":"10.1016\/j.drudis.2018.05.020_bib0150","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1039\/B816215H","article-title":"Antimicrobial nucleoside antibiotics targeting cell wall assembly: recent advances in structure-function studies and nucleoside biosynthesis","volume":"27","author":"Winn","year":"2010","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.drudis.2018.05.020_bib0155","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1039\/b202149h","article-title":"Recent advances in antimicrobial nucleoside antibiotics targeting cell wall biosynthesis","volume":"20","author":"Kimura","year":"2003","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.drudis.2018.05.020_bib0160","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2174\/156802605774463042","article-title":"MraY inhibitors as novel antibacterial agents","volume":"5","author":"Dini","year":"2005","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.drudis.2018.05.020_bib0165","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.2174\/0929867322666150818103502","article-title":"Antibacterial nucleoside natural products inhibiting phospho-MurNAc-pentapeptide translocase; chemistry and structure\u2013activity relationship","volume":"22","author":"Ichikawa","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.drudis.2018.05.020_bib0170","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1016\/j.bmc.2016.03.018","article-title":"Inhibition of phospho-MurNAc-pentapeptide translocase (MraY) by nucleoside natural product antibiotics, bacteriophage varphiX174 lysis protein E, and cationic antibacterial peptides","volume":"24","author":"Bugg","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2018.05.020_bib0175","doi-asserted-by":"crossref","first-page":"215","DOI":"10.7164\/antibiotics.24.215","article-title":"Tunicamycin, a new antibiotic. I. Isolation and characterization of tunicamycin","volume":"24","author":"Takatsuki","year":"1971","journal-title":"J. Antibiot."},{"key":"10.1016\/j.drudis.2018.05.020_bib0180","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/ja.2017.101","article-title":"Modified tunicamycins with reduced eukaryotic toxicity that enhance the antibacterial activity of beta-lactams","volume":"70","author":"Price","year":"2017","journal-title":"J. Antibiot."},{"key":"10.1016\/j.drudis.2018.05.020_bib0185","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/1087057104272007","article-title":"Development of a microplate-based scintillation proximity assay for MraY using a modified substrate","volume":"10","author":"Solapure","year":"2005","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.drudis.2018.05.020_bib0190","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-4165(98)00140-8","article-title":"Investigation of the glycosyltransferase enzymes involved in the initial stages of the N-linked protein glycosylation pathway in Aspergillus niger","volume":"1426","author":"Wallis","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2018.05.020_bib0195","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/978-3-319-11280-0_22","article-title":"N-acetylglucosaminyl 1-phosphate transferase: an excellent target for developing new generation breast cancer therapeutic","volume":"842","author":"Banerjee","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.drudis.2018.05.020_bib0200","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1016\/S0960-894X(02)00469-9","article-title":"Muraymycins, novel peptidoglycan biosynthesis inhibitors: semisynthesis and SAR of their derivatives","volume":"12","author":"Lin","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2018.05.020_bib0205","doi-asserted-by":"crossref","first-page":"10260","DOI":"10.1021\/ja017748h","article-title":"Structures of the muraymycins, novel peptidoglycan biosynthesis inhibitors","volume":"124","author":"McDonald","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.drudis.2018.05.020_bib0210","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3762\/bjoc.12.77","article-title":"Muraymycin nucleoside-peptide antibiotics: uridine-derived natural products as lead structures for the development of novel antibacterial agents","volume":"12","author":"Wiegmann","year":"2016","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.drudis.2018.05.020_bib0215","doi-asserted-by":"crossref","first-page":"8421","DOI":"10.1021\/jm200906r","article-title":"Mechanistic analysis of muraymycin analogues: a guide to the design of MraY inhibitors","volume":"54","author":"Tanino","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2018.05.020_bib0220","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1021\/ml5000096","article-title":"Expansion of antibacterial spectrum of muraymycins toward Pseudomonas aeruginosa","volume":"5","author":"Takeoka","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2018.05.020_bib0225","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/cmdc.201700793","article-title":"Insights into the target interaction of naturally occurring muraymycin nucleoside antibiotics","volume":"13","author":"Koppermann","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.drudis.2018.05.020_bib0230","unstructured":"Carter, G.T. et al. (2002) (American Cyanamid Company), Int. PCT Pub. No. WO02085310 A2, 2002; 9a,9b,9c"},{"key":"10.1016\/j.drudis.2018.05.020_bib0235","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1021\/ml100057z","article-title":"Synthesis and biological evaluation of muraymycin analogues active against anti-drug-resistant bacteria","volume":"1","author":"Tanino","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2018.05.020_bib0240","doi-asserted-by":"crossref","first-page":"15057","DOI":"10.1074\/jbc.M116.717884","article-title":"New insight into the catalytic mechanism of bacterial MraY from enzyme kinetics and docking studies","volume":"291","author":"Liu","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2018.05.020_bib0245","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0960-894X(00)00349-8","article-title":"Synthesis of the nucleoside moiety of liposidomycins: elucidation of the pharmacophore of this family of MraY inhibitors","volume":"10","author":"Dini","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2018.05.020_bib0250","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1021\/jm100243n","article-title":"Function-oriented synthesis of simplified caprazamycins: discovery of oxazolidine-containing uridine derivatives as antibacterial agents against drug-resistant bacteria","volume":"53","author":"Ii","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2018.05.020_bib0255","doi-asserted-by":"crossref","first-page":"15292","DOI":"10.1002\/chem.201404775","article-title":"Lead structures for new antibacterials: stereocontrolled synthesis of a bioactive muraymycin analogue","volume":"20","author":"Spork","year":"2014","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.drudis.2018.05.020_bib0260","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajhg.2012.05.022","article-title":"Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates","volume":"91","author":"Belaya","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.drudis.2018.05.020_bib0265","doi-asserted-by":"crossref","first-page":"14214","DOI":"10.1074\/jbc.272.22.14214","article-title":"Oligomerization of hamster UDP-GlcNAc:dolichol-P GlcNAc-1-P transferase, an enzyme with multiple transmembrane spans","volume":"272","author":"Dan","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2018.05.020_bib0270","doi-asserted-by":"crossref","first-page":"16303","DOI":"10.1016\/S0021-9258(17)36236-1","article-title":"Purification and properties of UDP-GlcNAc:dolichyl-phosphate GlcNAc-1-phosphate transferase. Activation and inhibition of the enzyme","volume":"260","author":"Kaushal","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2018.05.020_bib0275","doi-asserted-by":"crossref","first-page":"30717","DOI":"10.1074\/jbc.271.48.30717","article-title":"Hamster UDP-N-acetylglucosamine:dolichol-P N-acetylglucosamine-1-P transferase has multiple transmembrane spans and a critical cytosolic loop","volume":"271","author":"Dan","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2018.05.020_bib0280","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1021\/jo9027193","article-title":"Total synthesis of (\u2212)-muraymycin D2 and its epimer","volume":"75","author":"Tanino","year":"2010","journal-title":"J. Org Chem."},{"key":"10.1016\/j.drudis.2018.05.020_bib0285","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1002\/anie.201501890","article-title":"A modular approach to the total synthesis of tunicamycins","volume":"54","author":"Li","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.drudis.2018.05.020_bib0290","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/anie.201411954","article-title":"Total synthesis of (\u2212)-caprazamycin A","volume":"54","author":"Nakamura","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.drudis.2018.05.020_bib0295","doi-asserted-by":"crossref","first-page":"12975","DOI":"10.1021\/jacs.6b07395","article-title":"Stereocontrolled total synthesis of muraymycin D1 having a dual mode of action against Mycobacterium tuberculosis","volume":"138","author":"Mitachi","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.drudis.2018.05.020_bib0300","doi-asserted-by":"crossref","first-page":"14414","DOI":"10.1038\/ncomms14414","article-title":"Sansanmycin natural product analogues as potent and selective anti-mycobacterials that inhibit lipid I biosynthesis","volume":"8","author":"Tran","year":"2017","journal-title":"Nat. Commun."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644617304944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644617304944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:34:50Z","timestamp":1761222890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644617304944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1359644617304944"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2018.05.020","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural basis for selective inhibition of antibacterial target MraY, a membrane-bound enzyme involved in peptidoglycan synthesis","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2018.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}